JP2004529158A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529158A5 JP2004529158A5 JP2002584967A JP2002584967A JP2004529158A5 JP 2004529158 A5 JP2004529158 A5 JP 2004529158A5 JP 2002584967 A JP2002584967 A JP 2002584967A JP 2002584967 A JP2002584967 A JP 2002584967A JP 2004529158 A5 JP2004529158 A5 JP 2004529158A5
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- individual
- pharmaceutical composition
- carrying
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 229920002287 Amplicon Polymers 0.000 claims 8
- 241000700605 Viruses Species 0.000 claims 6
- 230000002950 deficient Effects 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 230000002588 toxic Effects 0.000 claims 5
- 231100000331 toxic Toxicity 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 230000003612 virological Effects 0.000 claims 4
- 210000000987 Immune System Anatomy 0.000 claims 3
- 230000002708 enhancing Effects 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28771701P | 2001-05-02 | 2001-05-02 | |
| PCT/IL2002/000345 WO2002087625A1 (en) | 2001-05-02 | 2002-05-02 | Composite oncolytic herpes virus vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004529158A JP2004529158A (ja) | 2004-09-24 |
| JP2004529158A5 true JP2004529158A5 (ro) | 2005-12-22 |
Family
ID=23104029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002584967A Pending JP2004529158A (ja) | 2001-05-02 | 2002-05-02 | 混成殺腫瘍ヘルペスウイルスベクター |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1406668A1 (ro) |
| JP (1) | JP2004529158A (ro) |
| WO (1) | WO2002087625A1 (ro) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| WO2002056828A2 (en) | 2000-11-29 | 2002-07-25 | University Of Rochester | Helper virus-free herpes virus amplicon particles and uses thereof |
| US8092791B2 (en) | 2001-05-23 | 2012-01-10 | University Of Rochester | Method of producing herpes simplex virus amplicons, resulting amplicons, and their use |
| AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| WO2004064765A2 (en) * | 2003-01-23 | 2004-08-05 | University Of Rochester | Herpesvirus amplicon particles |
| TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379674B1 (en) * | 1997-08-12 | 2002-04-30 | Georgetown University | Use of herpes vectors for tumor therapy |
| GB9816781D0 (en) * | 1998-07-31 | 1998-09-30 | Univ London | Herpes virus vectors for dendritic cells |
| US6774119B1 (en) * | 1999-04-26 | 2004-08-10 | Cedars-Sinai Medical Center | Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
-
2002
- 2002-05-02 WO PCT/IL2002/000345 patent/WO2002087625A1/en not_active Application Discontinuation
- 2002-05-02 JP JP2002584967A patent/JP2004529158A/ja active Pending
- 2002-05-02 EP EP02766686A patent/EP1406668A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR021876A1 (es) | Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado | |
| CN1094642A (zh) | 治疗组合物 | |
| JP2005506957A (ja) | ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンｂ１２およびインターフェロンを用いた複合治療 | |
| JP2003535043A5 (ro) | ||
| RU2007105354A (ru) | Применение комбинации циклоспорина и пэгилированного интерферона для лечения гепатита с (hcv) | |
| JP2009504157A5 (ro) | ||
| TW200716095A (en) | Method of treating interferon non-responders using HCV protease inhibitor | |
| JP2005533021A5 (ro) | ||
| WO2008024843A3 (en) | Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein | |
| RU2012136824A (ru) | Способы лечения вирусной инфекции гепатита с | |
| US20110165119A1 (en) | Telaprevir dosing regimen | |
| JP2004529158A5 (ro) | ||
| CN1835765A (zh) | 治疗病毒感染的方法 | |
| JP2007501806A5 (ro) | ||
| AR022116A1 (es) | Terapia de combinacion para el vhc por induccion de ribavirina - interferon alfa | |
| JP2003514025A5 (ro) | ||
| TWI524895B (zh) | Ｃ型肝炎病毒感染之新治療方法 | |
| WO1990004977A3 (en) | Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon | |
| CN103096885A (zh) | 不饱和脂肪酸用于抑制病毒复制和/或感染的用途 | |
| WO2002006343A3 (en) | Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau | |
| WO2005016288A3 (en) | Methods and compositions for treatment of viral diseases | |
| JP2005502585A5 (ro) | ||
| JP2017514834A5 (ro) | ||
| JP2014509628A (ja) | Ｃ型肝炎ウイルス感染症を治療するためのアリスポリビル | |
| EA200900558A1 (ru) | Композиции аполактоферрина и способы их применения в лечении вирусного гепатита с |